These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11711287)

  • 1. The synthesis of [26,27-11C]dihydroxyvitamin D(3), a tracer for positron emission tomography (PET).
    Bonasera TA; Grue-Sørensen G; Ortu G; Binderup E; Bergström M; Björkling F; Långström B
    Bioorg Med Chem; 2001 Dec; 9(12):3123-8. PubMed ID: 11711287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.
    Boyan BD; Sylvia VL; McKinney N; Schwartz Z
    J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging.
    Hara T; Yuasa M
    Appl Radiat Isot; 1999 Mar; 50(3):531-3. PubMed ID: 10070713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3.
    Norman AW; Okamura WH; Bishop JE; Henry HL
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):1-13. PubMed ID: 12431790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of 11C-labeled fluoroclorgyline: a monoamine oxidase A specific inhibitor for positron emission tomography.
    Ohmomo Y; Hirata M; Murakami K; Magata Y; Tanaka C; Yokoyama A
    Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):1994-7. PubMed ID: 8293522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalization at C-12 of 1alpha,25-dihydroxyvitamin D(3) strongly modulates the affinity for the vitamin D receptor (VDR).
    González-Avión XC; Mouriño A
    Org Lett; 2003 Jun; 5(13):2291-3. PubMed ID: 12816431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
    Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
    Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of [isopropyl-11C]nimodipine for in vivo studies of dihydropyridine binding in man using positron emission tomography.
    Stone-Elander S; Roland P; Schwenner E; Halldin C; Widén L
    Int J Rad Appl Instrum A; 1991; 42(9):871-5. PubMed ID: 1657834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
    Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
    Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro binding of vitamin D receptor occupied by 24R,25-dihydroxyvitamin D3 to vitamin D responsive element of human osteocalcin gene.
    Uchida M; Ozonco K; Pike JW
    J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):181-7. PubMed ID: 9191975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.
    Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S
    Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies.
    Sihver W; Fasth KJ; Ogren M; Bivehed H; Bergström M; Nordberg A; Watanabe Y; Långström B
    J Neurochem; 1998 Oct; 71(4):1750-60. PubMed ID: 9751211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor?
    Mohr SC; Swamy N; Xu W; Ray R
    Steroids; 2001; 66(3-5):189-201. PubMed ID: 11179726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand.
    James ML; Fulton RR; Henderson DJ; Eberl S; Meikle SR; Thomson S; Allan RD; Dolle F; Fulham MJ; Kassiou M
    Bioorg Med Chem; 2005 Nov; 13(22):6188-94. PubMed ID: 16039131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of [11C] radioligands with high specific radioactivity on a commercial PET tracer synthesizer.
    Matarrese M; Soloviev D; Todde S; Neutro F; Petta P; Carpinelli A; Brüssermann M; Galli Kienle M; Fazio F
    Nucl Med Biol; 2003 Jan; 30(1):79-83. PubMed ID: 12493546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
    de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
    J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.